期刊文献+

钙磷脂结合蛋白Ⅱ在食管鳞癌组织中的表达及临床意义

The expression and clinical significance of AnnexinⅡ in esophageal squamous cell cancer
下载PDF
导出
摘要 目的研究钙磷脂结合蛋白Ⅱ(AnnexinⅡ)在食管鳞癌及癌旁组织中的表达,分析其与食管鳞癌临床病理特征间的关系。方法应用免疫组化法检测AnnexinⅡ在41例食管鳞癌组织及配对的癌旁组织、10例正常胃组织中的表达。结果 AnnexinⅡ蛋白在食管鳞癌组织中的表达明显高于癌旁组织及正常组织,差异具有统计学意义(P<0.05)。食管鳞癌组织中AnnexinⅡ的表达水平与肿瘤分化程度及淋巴结是否转移相关(P<0.05),而与年龄、性别、浸润深度、临床分期无关(均P>0.05)。结论AnnexinⅡ的表达在食管鳞癌的发生、发展过程中起重要作用,有望作为食管鳞癌诊治的新靶点。 Objective To expcore the expression and clinical significance of AnnexinⅡin esophageal squamous cell cancer and analyze the relationship between AnnexinⅡand clinicopathological features. Methods Im-munohistochemistry was used to detect the expression of AnnexinⅡamong 41 matched pairs of esophageal squamous cell cancer tissues and 10 cases of normal esophageal tissues. Results There were obviously differences in the expression of AnnexinⅡin esophageal squamous cell cancer tissues, circa-cancerous tissues and normal esophageal tissues(P〈0. 05). In the specimens of esophageal squamous cell cancer, expression of AnnexinⅡrelated to cell differentiation of tumors and metastasis of lymph node, no relation to age, sex, depth of invasion and clinical stage(P〉0. 05). Conclusions The expressions of AnnexinⅡhad important effect in development and growth in esophageal squamous cell cancer, and might become a diagnosis index and treating target in clinic treatment.
出处 《中国肿瘤外科杂志》 CAS 2015年第2期86-88,共3页 Chinese Journal of Surgical Oncology
关键词 钙磷脂结合蛋白Ⅱ 食管鳞癌 淋巴结转移 肿瘤分化 esophageal squamous cell cancer lymph node metastasis tumor cell dif-ferentiation
  • 相关文献

参考文献11

  • 1魏玲,李苏宜,曹苏生.Bmi-1在食管鳞癌组织中的表达及意义[J].中国肿瘤外科杂志,2010,2(5):279-281. 被引量:2
  • 2Nakajima M, Kato H. Treatment options for esophageal squamous cell carcinoma[J]. Expert Opin Pharmacother, 2013, 14(10) : 1345-1354.
  • 3Driieker P, Pejie M, Galla HJ, et al. Lipid segregation and mem- brane budding induced by the peripheral membrane binding protein annexin A2 [ J]. J Biol Chem, 2013, 288 (34) :24764-24776.
  • 4Sharma MC, Sharma M. The role of annexin 1I in angiogenesis and tumor progression: a potential therapeutic target [ J ]. Curr Pharm Des, 2007, 13(35) :3568-3575.
  • 5王波,张华,卢康平.膜联蛋白Ⅰ在非小细胞肺癌中的表达及临床意义[J].中国医药导报,2012,9(14):77-79. 被引量:1
  • 6Bharadwaj A, Bydoun M, Holloway R, et al Annexin A2 heterotet- tamer: structure and function[J]. Int J Mol Sci, 2013, 14(3) : 6259-6305.
  • 7Nedjadi T, Kitteringham N, Campbell F, et al. S10OA6 binds to annexin lI in pancreatic cancer cells and promotes pancreatic cancer cell motility [ ] ]. Br J Cancer, 2009, 101 ( 7 ) : 1145-1154.
  • 8Ohno Y, Izumi M, Kawamura T, et al. Annexin II represents metastatic potential in clear-cell renal cell carcinoma [ J ]. Br J Cancer, 2009, 101 (2) :287-294.
  • 9苏红英,黄雄飞,马创,刘景丰,王斌,高美钦,黄爱民.钙磷脂结合蛋白Ⅱ在人肝细胞癌组织的表达及其临床意义[J].中华实验外科杂志,2012,29(10):1896-1898. 被引量:3
  • 10党秋红,叶明,曾宪旭,李道明,班振英,张威,张欢,曹静,郝志伟,王玉萍.MMP-9和Annexin Ⅱ蛋白在乳腺癌组织中的表达及意义[J].肿瘤预防与治疗,2011,24(4):146-149. 被引量:2

二级参考文献34

  • 1Ishibashi Y, Matsumoto T, Niwa M, et al. CD147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma[ J]. Cancer,2004, 101 (9) :1994-2000.
  • 2Guo H, Zucker S, Gordon MK, et al. Stimulation of matrixmetal- loproteinase production by recombinant extraeellular matrixmetallo- proteinase inducer from transfected Chinese hamster ovary cells [J]. J Biol Chem, 1997, 272(1); 24-27.
  • 3Sidhu SS, Nawroth R, Retz M, et al. EMMPRIN regulates the ca- nonical Wnt/beta-catenin signaling pathway, a potential role in accelerating lung tumorigenesis [ J ]. Oncogene, 2010,29 ( 29 ) : 4145-56.
  • 4Frierson HF, Wolber RA, Berean KR, et al. Interobserver repro- ducibity of Nottingham modification of the Bloom and Richardson histologic grading Scheme for infiltating ductal carcinoma[ J]. Am J Clin Patho, 1995, 103 (2) : 195-198.
  • 5Westermarck J, Kihari VM. Regulation of matrix metalloproteinases in tumor invasion [ J ]. FASEB J, 1999,13 ( 8 ) :781 - 792.
  • 6Basset P, Okada A, Chenard MP, et al. Matelloproteinases as stromal effectors of human carcinoma progression:therapeutic im- plication [J]. Matrix Bio, 1997,15(8-9) :535-541.
  • 7Sledge GW. Implications of the new biology for therapy in breast cancer [J]. Semin Oncol, 1996, 23( 1 Suppl 2) :76-81.
  • 8Maeta H, Ohgi S, Terada T, et al. Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloprotein- ase 1 and 2 in papillary throid carcinomas [J]. Virchows Arch, 2001,438(2) :121-128.
  • 9Davies B, Waxman J, Wasan H, et al. Level of matrix metallopro- tease in bladder cancer correlate with tumor grade and invasion [J]. Cancer Res, 1993,53(22) :5365-5369.
  • 10Baker EA, Stephenson TJ, Reed MWR, et al. Expression of pro- teinases and inhibitors in human breast cancer progresion and sur- vival [J]. J Clin Pathol Mol Pathol, 2002, 55(5) : 300-304.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部